[ad_1]
While in Croatia they wait to wait for the summer and not even all those who are at risk will be vaccinated, Serbia, “as is well known throughout the EU, is incomparably better,” says the Zagreb portal.
It is added that even vaccines that it requested less from Croatia, such as AstraZeneca and Pfizer, arrive in Serbia more regularly.
According to the text, in this situation, Serbia has made good use of its geopolitical position of independence from the EU on the one hand and its good diplomatic relations with Russia and China on the other.
Serbia, which signed a preliminary agreement with Pfizer in October on the delivery of 350,000 doses at the end of March, while Croatia ordered one million doses.
So far, Serbia has received about 90,000 doses of the Pfizer vaccine, exactly on the dates and in the amounts announced by President Aleksandar Vučić, while Croatia, which ordered nearly three times as many, received about 156,000, the index notes.
The text also cites a report obtained from the Serbian embassy, showing the organization and rate at which Serbia purchases vaccines and vaccinates citizens.
– Citizens can choose the vaccine they want to receive and have access to: Pfizer, Chinese Sinofarm, Russian Sputnik Ve and AstraZeneca. Serbia has 181,000 vaccinated people per million inhabitants (as of March 5, more than 20% of citizens have been vaccinated; it is written, among other things, in the email from the Serbian embassy that was received by the Croatian media some days ago ).
About five percent of Croatia’s population has been vaccinated so far, the Index notes.
It is also claimed that “independent players are doing better.”
– You can draw a parallel with a teacher who is going to do a job in a new house, although he did not finish the job in the first, which has already started, and which has already been partially paid for – the first one is safe – writes Index.
The big problem in the whole story is the bad contracts the EU has made with producers, Indeks writes.
It is added that the EU subsequently ordered vaccines, but could still benefit from the increased supply at the end of the year, when the American company Moderna increases its production.
Follow us through iOS and Android apps
[ad_2]
